FDLC 001
Alternative Names: FDLC-001Latest Information Update: 11 Nov 2024
Price :
$50 *
At a glance
- Originator ForDoz Pharma
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Pain
Most Recent Events
- 22 Oct 2024 Early research in Pain in USA (Parenteral), prior to October 2024 (ForDoz Pharma pipeline, October 2024)